These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5692338)

  • 1. Comparison of blood levels with oral and intramuscular diphenylhydantoin.
    Cantu RC; Schwab RS; Timberlake WH
    Neurology; 1968 Aug; 18(8):782-4. PubMed ID: 5692338
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin.
    Serrano EE; Roye DB; Hammer RH; Wilder BJ
    Neurology; 1973 Mar; 23(3):311-7. PubMed ID: 4735181
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of blood levels with oral vs. intramuscular diphenylhydantoin.
    Cantu RC; Schwab RS; Timberlake WH
    Neurology; 1968 Mar; 18(3):283-4. PubMed ID: 5690352
    [No Abstract]   [Full Text] [Related]  

  • 4. A method for shifting from oral to intramuscular diphenylhydantoin administration.
    Wilder BJ; Serrano EE; Ramsey E; Buchanan RA
    Clin Pharmacol Ther; 1974 Sep; 16(3):507-13. PubMed ID: 4411662
    [No Abstract]   [Full Text] [Related]  

  • 5. Inadequate serum levels after intramuscular administration of diphenylhydantoin.
    Wilensky AJ; Lowden JA
    Neurology; 1973 Mar; 23(3):318-24. PubMed ID: 4735182
    [No Abstract]   [Full Text] [Related]  

  • 6. Diphenylhydantoin and epilepsy management.
    Easton JD
    Ann Intern Med; 1972 Sep; 77(3):421-3. PubMed ID: 5053732
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous diphenylhydantoin in treatment of acute repetitive seizures.
    Wallis W; Kutt H; McDowell F
    Neurology; 1968 Jun; 18(6):513-25. PubMed ID: 4969740
    [No Abstract]   [Full Text] [Related]  

  • 8. [5,5-Diphenylhydantoin (hydantoinal Polfa)].
    Pakszys W
    Neurol Neurochir Pol; 1973; 7(1):79-84. PubMed ID: 4570505
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral and intramuscular phenytoin.
    Wilder BJ; Ramsay RE
    Clin Pharmacol Ther; 1976 Mar; 19(3):360-4. PubMed ID: 770051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One daily dose of diphenylhydantoin for patients with epilepsy.
    Strandjord RE; Johannessen SI; Halpern LM
    Epilepsia; 1974 Sep; 15(3):317-27. PubMed ID: 4527914
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of the effect of 5,5-diphenylhydantoin on the bioelectric activity of the brain in epilepsy].
    Domzal T; Gajkowski K
    Neurol Neurochir Pol; 1971; 5(3):301-6. PubMed ID: 5000628
    [No Abstract]   [Full Text] [Related]  

  • 12. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children.
    Buchanan RA; Allen RJ
    Neurology; 1971 Aug; 21(8):866-71. PubMed ID: 5106302
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum level determination in patients with acute myocardial infarction under diphenylhydantoin therapy].
    Kettner W; Quednow B; Wilckens H; Walther H
    Z Gesamte Inn Med; 1979 Oct; 34(20):suppl 282-4. PubMed ID: 549293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular diphenylhydantoin.
    Cote JR
    Ann Intern Med; 1973 Jun; 78(6):980-1. PubMed ID: 4713589
    [No Abstract]   [Full Text] [Related]  

  • 16. Early post-traumatic epilepsy prophylaxis.
    Young B; Rapp RP; Perrier D; Kostenbauder H; Hackman J; Blacker HM
    Surg Neurol; 1975 Sep; 4(3):339-42. PubMed ID: 809855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphenylhydantoin-induced asterixis. A clinical study.
    Murphy MJ; Goldstein MN
    JAMA; 1974 Jul; 229(5):538-40. PubMed ID: 4406897
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacodynamic aspects of phenobarbital (PB) and diphenylhydantoin (DPH). Correlations with clinical findings].
    Denegri M; Luciano L
    Rev Neuropsychiatr Infant; 1972; 20(3):375-83. PubMed ID: 5055027
    [No Abstract]   [Full Text] [Related]  

  • 19. Variations of serum diphenylhydantoin concentrations in epileptic out-patients.
    Vapaatalo H; Lehtinen L
    Eur Neurol; 1971; 5(5):303-10. PubMed ID: 5133553
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of serum diphenylhydantoin during antiepileptic therapy].
    Müller-Stüler M
    Nervenarzt; 1976 Apr; 47(4):244-7. PubMed ID: 1272481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.